The S&P 500 futures currently trade two points above fair value.
Microchip (MCHP 69.69, +2.63, +3.9%) is nicely higher in the premarket after guiding its Q3 (December) revenue above consensus, experiencing a fairly broad-based recovery in most of its end markets.
In other earnings and guidance news, AngioDynamics (ANGO 13.85, +0.62, +4.7%) is higher after beating EPS expectations by $0.10, beating revenue expectations, and reaffirming its FY26 EPS guidance while guiding FY26 revenues above consensus. The company's CEO will retire during FY27.